Entity > Corporation > US > New York City New York > Surface Oncology
About Surface Oncology
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Surface Oncology
| Company Attribute | Value |
| Name | Surface Oncology |
| Url | surfaceoncology |
Surface Oncology
New York City, US
4 May 2024
Surface Oncology
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://investors.coherus.com › news-release-details › coh...
(Surface, Nasdaq: SURF) today announced that the companies have entered into a definitive merger agreement providing that, at the closing, Coherus will acquire ...
People Also Ask
https://investors.coherus.com › news-release-details › coh...
Sep 8, 2023 — Through its acquisition of Surface Oncology, Coherus' immuno-oncology pipeline will now include multiple antibody immunotherapy candidates ...
https://www.linkedin.com/company/surface-oncology
We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology ...
https://www.biospace.com › employer › surface-oncolo...
Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, ...
https://www.goodwinlaw.com › news › 2023/06 › annou...
Jun 16, 2023 — The Life Sciences and Technology teams advised Surface Oncology (Nasdaq: SURF) in its entry into a definitive merger agreement with Coherus ...
https://www.pharmaceutical-technology.com › news › c...
Jun 19, 2023 — Coherus BioSciences has signed a definitive merger agreement to buy clinical-stage I-O company Surface Oncology, in a deal valued at $65m.
https://www.marketwatch.com › story › surface-oncolo...
Jun 16, 2023 — Surface Oncology Inc. SURF stock is up 49% in premarket trades on Friday after the cancer drug company agreed to be acquired by Coherus ...
https://www.pharmaceutical-technology.com › news › c...
Sep 11, 2023 — Coherus BioSciences has concluded the acquisition of immuno-oncology (I-O) company Surface Oncology in a deal totalling nearly $66.9m.
https://www.bloomberg.com › company › SURF:US
Surface Oncology, Inc. operates as an immuno-oncology company. The Company develops therapies for the treatment of cancer. Surface Oncology serves clients ...
https://finance.yahoo.com › news › surface-oncology-a...
Aug 31, 2023 — “We believe the proposed merger offers a unique and critical opportunity for Surface stockholders--the benefits are clear,” commented Rob Ross, ...
Related Searches
surface oncology stock
surface oncology cvr
surface oncology pipeline
Knowledge Panel
Surface Oncology, Inc. (Company)
-
Parent organization : Coherus BioSciences
-
Founded : 2014
| Entity Home | Kalicube Pro Entity Page |